{"abstract": "This month Pfizer\u2019s chief executive, Jeffrey B. Kindler, held a breakfast for venture capitalists atop a hotel in San Francisco. Some guests took it as a sign that Pfizer was serious about buying young biotechnology companies or licensing their technology.", "web_url": "https://dealbook.nytimes.com/2009/01/27/wyeth-deal-may-slow-pfizer-biotech-acquisitions/", "snippet": "", "lead_paragraph": "This month Pfizer\u2019s chief executive, Jeffrey B. Kindler, held a breakfast for venture capitalists atop a hotel in San Francisco. Some guests took it as a sign that Pfizer was serious about buying young biotechnology companies or licensing their technology.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Wyeth Deal May Slow Pfizer Biotech Acquisitions", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-01-27T12:10:58+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/1fc7fe3f-c92e-5298-9a5f-e1602e186ea5", "word_count": 869, "uri": "nyt://article/1fc7fe3f-c92e-5298-9a5f-e1602e186ea5"}